Literature DB >> 19558219

Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.

Atsushi Kunisato1, Mariko Wakatsuki, Yuuki Kodama, Haruna Shinba, Isao Ishida, Kenji Nagao.   

Abstract

Reprogramming of somatic cells provides potential for the generation of specific cell types, which could be a key step in the study and treatment of human diseases. In vitro reprogramming of somatic cells into a pluripotent embryonic stem (ES) cell-like state has been reported by retroviral transduction of murine fibroblasts using four embryonic transcription factors or through cell fusion of somatic and pluripotent stem cells. Here we show that mouse adult bone marrow mononuclear cells (BM MNCs) are competent as donor cells and can be reprogrammed into pluripotent ES cell-like cells. We isolated BM MNCs and mouse embryonic fibroblasts (MEFs) from Oct4-GFP transgenic mice, fused them with ES cells, or infected them with retroviruses expressing Oct4, Sox2, Klf4, and c-Myc. Fused BM MNCs formed more ES-like colonies than did MEFs. Infected BM MNCs gave rise to induced pluripotent stem (iPS) cells, although transduction efficiencies were not high. It was more efficient to pick up iPS colonies as compared with MEFs. BM-derived iPS (BM iPS) cells expressed ES cell markers, formed teratomas, and contributed to chimera mice with germ line development. Clonal analysis revealed that BM iPS clones had diversity, although some clones were found to be genetically identical with different phenotypes. Our findings imply that BM MNCs have potential advantages to generate iPS cells for the clinical application.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19558219     DOI: 10.1089/scd.2009.0149

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  22 in total

1.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

2.  An effective statistical evaluation of ChIPseq dataset similarity.

Authors:  Maria D Chikina; Olga G Troyanskaya
Journal:  Bioinformatics       Date:  2012-01-19       Impact factor: 6.937

Review 3.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Authors:  Mong-Jen Chen; Yuanqing Lu; Takashi Hamazaki; Hsin-Yin Tsai; Kirsten Erger; Thomas Conlon; Ahmed S Elshikha; Hong Li; Arun Srivastava; Chunli Yao; Mark Brantly; Vince Chiodo; William Hauswirth; Naohiro Terada; Sihong Song
Journal:  Hum Gene Ther Methods       Date:  2013-12-28       Impact factor: 2.396

Review 5.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

6.  Generation of stomach tissue from mouse embryonic stem cells.

Authors:  Taka-aki K Noguchi; Naoto Ninomiya; Mari Sekine; Shinji Komazaki; Pi-Chao Wang; Makoto Asashima; Akira Kurisaki
Journal:  Nat Cell Biol       Date:  2015-07-20       Impact factor: 28.824

7.  Reprogramming of T cells from human peripheral blood.

Authors:  Yuin-Han Loh; Odelya Hartung; Hu Li; Chunguang Guo; Julie M Sahalie; Philip D Manos; Achia Urbach; Garrett C Heffner; Marica Grskovic; Francois Vigneault; M William Lensch; In-Hyun Park; Suneet Agarwal; George M Church; James J Collins; Stefan Irion; George Q Daley
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

8.  Induced pluripotency and oncogenic transformation are related processes.

Authors:  John W Riggs; Bonnie L Barrilleaux; Natasha Varlakhanova; Kelly M Bush; Vanessa Chan; Paul S Knoepfler
Journal:  Stem Cells Dev       Date:  2012-10-26       Impact factor: 3.272

9.  Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

Authors:  Xianmei Meng; Amanda Neises; Rui-Jun Su; Kimberly J Payne; Linda Ritter; Daila S Gridley; Jun Wang; Matilda Sheng; K-H William Lau; David J Baylink; Xiao-Bing Zhang
Journal:  Mol Ther       Date:  2011-11-22       Impact factor: 11.454

Review 10.  Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations.

Authors:  Rodrigo A Somoza; Jean F Welter; Diego Correa; Arnold I Caplan
Journal:  Tissue Eng Part B Rev       Date:  2014-05-27       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.